Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.4.0.3
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2016
Mar. 31, 2015
Current assets:    
Cash and cash equivalents $ 107.1 $ 67.0
Restricted cash and cash equivalents 5.0 5.0
Restricted cash and cash equivalents - Asbestos 17.0 22.0
Accounts and other receivables, net of allowance for doubtful accounts of US$1.1 million and US$0.8 million as of 31 March 2016 and 31 March 2015, respectively 173.3 133.3
Inventories 193.0 218.0
Prepaid expenses and other current assets 19.7 24.3
Insurance receivable - Asbestos 16.7 16.7
Workers' compensation - Asbestos 4.1 4.5
Deferred income taxes   17.3
Deferred income taxes - Asbestos   15.9
Total current assets 535.9 524.0
Property, plant and equipment, net 867.0 880.1
Insurance receivable - Asbestos 149.0 161.9
Workers' compensation - Asbestos 46.8 45.5
Deferred income taxes 25.9 12.9
Deferred income taxes - Asbestos 384.9 389.3
Other assets 30.9 30.8
Total assets 2,040.4 2,044.5
Current liabilities:    
Accounts payable and accrued liabilities 127.2 149.6
Short-term debt - Asbestos 50.7 13.6
Accrued payroll and employee benefits 63.0 60.6
Accrued product warranties 12.2 8.9
Income taxes payable 4.8 1.8
Asbestos liability 125.9 131.6
Workers' compensation - Asbestos 4.1 4.5
Other liabilities 11.9 7.3
Total current liabilities 399.8 377.9
Long-term debt 512.8 397.5
Deferred income taxes 82.1 88.9
Accrued product warranties 33.1 26.3
Asbestos liability 1,176.3 1,290.0
Workers' compensation - Asbestos 46.8 45.5
Other liabilities 14.7 21.0
Total liabilities $ 2,265.6 $ 2,247.1
Commitments and contingencies (Note 14)
Shareholders' deficit:    
Common stock, Euro 0.59 par value, 2.0 billion shares authorized; 445,579,351 shares issued at 31 March 2016 and 445,680,673 shares issued at 31 March 2015 $ 231.4 $ 231.2
Additional paid-in capital 164.4 153.2
Accumulated deficit (621.8) (586.6)
Accumulated other comprehensive income (loss) 0.8 (0.4)
Total shareholders' deficit (225.2) (202.6)
Total liabilities and shareholders' deficit $ 2,040.4 $ 2,044.5